The Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics market size is expected to reach $8.97 billion in 2030 at a CAGR of 8.2%, driven by rising diabetes prevalence.
Read More
The Ethical Pharmaceuticals market size is expected to reach $14.8 billion in 2030 at a CAGR of 13.2%, driven by rising chronic disease prevalence.
Read More
The Estrogen Replacement Therapy market size is expected to reach $12.51 billion in 2030 at a CAGR of 4.7%, driven by increasing telemedicine use.
Read More
The Estrogen Receptor Modulators market size is expected to reach $25.65 billion in 2030 at a CAGR of 8.4%, driven by rising breast cancer prevalence.
Read More
The Estrogen Blockers market size is expected to reach $14.16 billion in 2030 at a CAGR of 7.0%, driven by rising breast cancer prevalence.
Read More
The Esketamine market size is expected to reach $2.5 billion in 2030 at a CAGR of 10.6%, driven by rising treatment-resistant depression.
Read More
The Erythropoietin (EPO) market size is expected to reach $35.04 billion in 2030 at a CAGR of 13.0%, driven by rising chronic kidney disease.
Read More
The Erythrocytes Monoclonal Antibody market size is expected to reach $6.21 billion in 2030 at a CAGR of 12.3%, driven by rising blood disease prevalence.
Read More
The Erleada market size is expected to reach $4.7 billion in 2030 at a CAGR of 9.2%, driven by rising prostate cancer prevalence.
Read More
The Epinephrine market size is expected to reach $4.52 billion in 2030 at a CAGR of 9.5%, driven by rising chronic respiratory diseases.
Read More